| Dana Scott Nafts, RPH | |
|
2345 King Ave, Billings, MO 59102 | |
| (406) 651-2160 | |
| Not Available |
| Full Name | Dana Scott Nafts |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2345 King Ave, Billings, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124048038 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2546 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dana Scott Nafts, RPH 2025 Interlachen Dr, Billings, MT 59105-3650 Ph: (406) 259-4104 | Dana Scott Nafts, RPH 2345 King Ave, Billings, MO 59102 Ph: (406) 651-2160 |
News Archive
Passengers arriving from West Africa will have their temperatures taken at the airports. Meanwhile, questions are emerging about the care given to Thomas Eric Duncan, the Texas Ebola patient who died Wednesday, including why he was initially released from the hospital.
Researchers from Isis Pharmaceuticals (Carlsbad, CA) and Prysis Biotechnologies (Pudong, Shanghai, China) have demonstrated proof-of-concept for using a sense oligonucleotide to undo the effects of an antisense drug, an antithrombotic agent in this novel study.
A bioengineering professor at The University of Texas at Arlington is developing a technique to diagnose tiny breast tumors that could reduce the anxiety, uncertainty and high costs often faced by patients.
The New York Stem Cell Foundation Research Institute has entered into a partnership with the Parkinson's Progression Markers Initiative to build resources for studying Parkinson's disease to accelerate new treatments. Sponsored by The Michael J. Fox Foundation for Parkinson's Research, PPMI is a landmark effort to identify and validate biomarkers of Parkinson's disease.
Research teams from three academic institutions and two private sector companies on two continents have come together to form the International malaria research consortium for the development of novel classes of antimalarials. This bold initiative will develop novel classes of drugs against malaria, a deadly disease in desperate need of new treatments.
› Verified 6 days ago
Tasha Schalk, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 495 Wild Turkey Dr, Billings, MO 65610 Phone: 417-425-1205 |